MSC-4106

CAS No. 2738542-58-8

MSC-4106( —— )

Catalog No. M35343 CAS No. 2738542-58-8

MSC-4106, an orally active and potent YAP/TAZ-TEAD inhibitor, disrupts TEAD1 and TEAD3 auto-palmitoylation and demonstrates significant efficacy in the NCI-H226 tumor xenograft model .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 147 Get Quote
5MG 235 Get Quote
10MG 377 Get Quote
25MG 610 Get Quote
50MG 869 Get Quote
100MG 1152 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MSC-4106
  • Note
    Research use only, not for human use.
  • Brief Description
    MSC-4106, an orally active and potent YAP/TAZ-TEAD inhibitor, disrupts TEAD1 and TEAD3 auto-palmitoylation and demonstrates significant efficacy in the NCI-H226 tumor xenograft model .
  • Description
    MSC-4106 is an orally active and potent inhibitor of YAP/TAZ-TEAD. MSC-4106 inhibits TEAD1 or TEAD3 auto-palmitoylation and shows inhibitory effect on NCI-H226 tumor xenograft model.
  • In Vitro
    MSC-4106 (10 μM, 24 h) inhibited SK-HEP-1 reporter and NCI-266 cell viability with IC50 values of 4 nM and 14 nM, respectively.MSC-4106 (10 μM, 6 h) crystallizes in the P-site of TEAD1, and against TEAD1 or TEAD3 palmitoylation in TEAD-Overexpressing HEK293 Cells by 97.3% and 75.9%, respectively.MSC-4106 (10 μM, 4 d) targets TEAD indicated by a reduction in viability of NCI-H226 cells.Cell Viability Assay Cell Line:NCI-H226 (YAP dependent); SW620 YAP/TAZ KO (Yap-independent) cells Concentration:0, 3, 6, 9, 12, 15, 18, 21, 24, 26, 30 μM Incubation Time:96 hours Result:Showed inhibitory effect to NCI-H226 and general cytotoxic to SW620 (IC50 >30 μM).Immunofluorescence Cell Line:SK-HEP-1Concentration:0, 3, 6, 9, 12, 15, 18, 21, 24, 26, 30 μM Incubation Time:24 hours Result:Inhibited YAP-TEAD interation.
  • In Vivo
    MSC-4106 (100 mg/kg/d; p.o.; 7 d) displays anti-tumor effect with controlled tumor volume and good tolerability with stable body weight in mice.MSC-4106 (1, 5, 100 mg/kg/d; p.o.; 0-72 h) down-regulates Cyr61 (cysteine-rich angiogenic inducer 61) expression, the TEAD-regulated target gene, in tumor lysates at all time points at 100 mg/kg and 24 h at 5 mg/kg.Note: PO studies were performed at 10 mg/kg; MSC-4106 was formulated in 20% Kleptose in 50 mM PBS at pH 7.4.Animal Model:NCI-H226 xenograft model in H2d Rag2 female mice (9-week-old)Dosage:5, 100 mg/kg Administration:Oral gavage; once daily; 32 days Result:Resulted tumor growth controlled with 5 mg/kg while regressed with 100 mg/kg dosing after 32 treatment days.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    YAP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2738542-58-8
  • Formula Weight
    359.3
  • Molecular Formula
    C18H12F3N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (695.80 mM; Ultrasonic )
  • SMILES
    Cn1cc2c3cc(ccc3n(-c3ccc(cc3)C(F)(F)F)c2n1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Timo Heinrich, et al. Optimization of TEAD P-site binding fragment hit into in vivo active lead MSC-4106. J. Med. Chem. 2022, 65, 13, 9206–9229.?
molnova catalog
related products
  • Suberic acid

    Suberic acid is present in the urine of patients with fatty acid oxidation disorders. A metabolic breakdown product derived from oleic acid.

  • Sagittatoside A

    Sagittatoside A selectively activates estrogen response element (ERE)-luciferase activity via ERα.

  • [Ala92]-p16 (84-103)

    Peptide derived from the tumor suppressor protein p16; inhibits cyclin-dependent kinase-4 (cdk4)/cyclin D1 (IC50 ~ 1.5 μM) and binds to cdk6.